医学研究与教育
醫學研究與教育
의학연구여교육
Medical Research and Education
2015年
4期
5-9
,共5页
姜旭%王元松%张立英%杨景超%邢丽君%张爱玲%孙文亮
薑旭%王元鬆%張立英%楊景超%邢麗君%張愛玲%孫文亮
강욱%왕원송%장립영%양경초%형려군%장애령%손문량
复荣通脉胶囊%糖尿病周围神经病变%临床疗效
複榮通脈膠囊%糖尿病週圍神經病變%臨床療效
복영통맥효낭%당뇨병주위신경병변%림상료효
Furongtongmai capsule%diabetic peripheral neuropathy%clinical curative effect
目的:探讨复荣通脉胶囊治疗糖尿病周围神经病变的临床疗效。方法选择2013年1月至2015年1月医院收治的糖尿病周围神经病变患者97例,将其随机分为观察组49例、对照组48例,对照组采取西医治疗方案,观察组在对照组基础上联合运用复荣通脉胶囊,2组均治疗3个月,比较2组患者临床疗效、治疗前后症状积分、TCSS评分、神经传导速度以及安全性。结果观察组治疗总有效率为83.67%,对照组治疗总有效率为64.58%,2组差异具有统计学意义(P<0.05);2组患者治疗后临床症状积分、TCSS评分均较治疗前显著改善,且观察组改善情况显著优于对照组(P<0.05);2组患者治疗前双侧腓总神经运动神经、感觉神经的传速度无统计学意义(P>0.05),治疗后2组患者神经传导速度均明显改善(P<0.05),且观察组改善情况显著优于对照组(P<0.05)。结论复荣通脉胶囊联合西医营养神经、改善微循环常规方案治疗糖尿病周围神经病变疗效显著,可显著改善患者临床症状以及神经病变,值得临床推广运用。
目的:探討複榮通脈膠囊治療糖尿病週圍神經病變的臨床療效。方法選擇2013年1月至2015年1月醫院收治的糖尿病週圍神經病變患者97例,將其隨機分為觀察組49例、對照組48例,對照組採取西醫治療方案,觀察組在對照組基礎上聯閤運用複榮通脈膠囊,2組均治療3箇月,比較2組患者臨床療效、治療前後癥狀積分、TCSS評分、神經傳導速度以及安全性。結果觀察組治療總有效率為83.67%,對照組治療總有效率為64.58%,2組差異具有統計學意義(P<0.05);2組患者治療後臨床癥狀積分、TCSS評分均較治療前顯著改善,且觀察組改善情況顯著優于對照組(P<0.05);2組患者治療前雙側腓總神經運動神經、感覺神經的傳速度無統計學意義(P>0.05),治療後2組患者神經傳導速度均明顯改善(P<0.05),且觀察組改善情況顯著優于對照組(P<0.05)。結論複榮通脈膠囊聯閤西醫營養神經、改善微循環常規方案治療糖尿病週圍神經病變療效顯著,可顯著改善患者臨床癥狀以及神經病變,值得臨床推廣運用。
목적:탐토복영통맥효낭치료당뇨병주위신경병변적림상료효。방법선택2013년1월지2015년1월의원수치적당뇨병주위신경병변환자97례,장기수궤분위관찰조49례、대조조48례,대조조채취서의치료방안,관찰조재대조조기출상연합운용복영통맥효낭,2조균치료3개월,비교2조환자림상료효、치료전후증상적분、TCSS평분、신경전도속도이급안전성。결과관찰조치료총유효솔위83.67%,대조조치료총유효솔위64.58%,2조차이구유통계학의의(P<0.05);2조환자치료후림상증상적분、TCSS평분균교치료전현저개선,차관찰조개선정황현저우우대조조(P<0.05);2조환자치료전쌍측비총신경운동신경、감각신경적전속도무통계학의의(P>0.05),치료후2조환자신경전도속도균명현개선(P<0.05),차관찰조개선정황현저우우대조조(P<0.05)。결론복영통맥효낭연합서의영양신경、개선미순배상규방안치료당뇨병주위신경병변료효현저,가현저개선환자림상증상이급신경병변,치득림상추엄운용。
Objective To investigate the clinical efifcacy of Furongtongmai capsule in the treatment of diabetic peripheral neuropathy.Methods 97 cases of patients with diabetic peripheral neuropathy were diagnosed from January 2013 to January 2015, which were randomly divided into observation group(n=49)and control group(n=48). The control group were treated with western medicine treatment and the observation group were treated with Furongtongmai capsule on the basis of the treatment in the control group.Two sets of treatments were three months. A comparison of the clinical efficacy, symptom score before and after the treatment, TCSS score, nerve conduction velocity and Security in both groups were made.Results The total effective rate in the observation group was 83.67% and that in the control group ws 64.58%, there was a statistical signiifcance(P<0.05); after the treatments, the symptom score and TCSS score in both groups were signiifcantly better than that of the before treatment, and the symptom score and TCSS score in the observation group were signiifcantly superior to that of the control group(P<0.05). There was no difference in bilateral peroneal nerve motor nerve and sensory nerve of transmission speed before the treatment(P>0.05). The NCV in both groups were signiifcantly improved after the treatment(P>0.05), and the mend matters in the observation group were significantly superior to the control group(P<0.05).Conclusion The clinical efficacy of the Furongtongmai capsule combined with western medicine for nourishing the nerves and improving micro-circulation of conventional scheme is signiifcant, which can signiifcantly improve the clinical symptoms and neuropathy, it is worthy to be popularized and applied.